CD103+/PD-1+T-cells identify a subset of triple-negative breast cancer eligible for targeted checkpoint inhibition Meeting Abstract


Authors: Bottai, G.; Loi, S.; Sotiriou, C.; Roncalli, M.; Pusztai, L.; Reis, J. S.; Santarpia, L.
Abstract Title: CD103+/PD-1+T-cells identify a subset of triple-negative breast cancer eligible for targeted checkpoint inhibition
Meeting Title: 2016 San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 77
Issue: 4 Suppl.
Meeting Dates: 2016 Dec 6-10
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2017-02-01
Language: English
ACCESSION: WOS:000397999000355
DOI: 10.1158/1538-7445.sabcs16-p2-04-16
PROVIDER: wos
Notes: Meeting Abstract: P2-04-16 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors